Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer
Autore:
Nicholson, RI; McClelland, RA; Robertson, JFR; Gee, JMW;
Indirizzi:
Univ Wales Coll Med, Tenovus Canc Res Ctr, Cardiff CF4 4XX, S Glam, Wales Univ Wales Coll Med Cardiff S Glam Wales CF4 4XX f CF4 4XX, S Glam, Wales City Hosp, Dept Surg, Nottingham NG5 1PB, England City Hosp Nottingham England NG5 1PB t Surg, Nottingham NG5 1PB, England
Titolo Testata:
ENDOCRINE-RELATED CANCER
fascicolo: 3, volume: 6, anno: 1999,
pagine: 373 - 387
SICI:
1351-0088(199909)6:3<373:IOSHAG>2.0.ZU;2-Q
Fonte:
ISI
Lingua:
ENG
Soggetto:
HUMAN ESTROGEN-RECEPTOR; PROTEIN-KINASE-C; MYC ONCOGENE EXPRESSION; CELL-CYCLE PROGRESSION; RAS-TRANSFORMED CELLS; NF-KAPPA-B; TYROSINE KINASE; FACTOR-ALPHA; RETINOIC ACID; MESSENGER-RNA;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
160
Recensione:
Indirizzi per estratti:
Indirizzo: Nicholson, RI Univ Wales Coll Med, Tenovus Canc Res Ctr, Cardiff CF4 4XX, S Glam, Wales Univ Wales Coll Med Cardiff S Glam Wales CF4 4XX lam, Wales
Citazione:
R.I. Nicholson et al., "Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer", ENDOCR-R CA, 6(3), 1999, pp. 373-387

Abstract

Multiple lines of evidence implicate steroid hormone and growth factor cross-talk as a modulator of endocrine response in breast cancer and that aberrations in growth factor signaling pathways are a common element in the endocrine resistant phenotype. Delineation of these relationships is thus an important diagnostic goal in cancer research, while the targeting of aberrant growth factor signaling holds the promise of improving therapeutic response rates.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/09/20 alle ore 09:48:12